Literature DB >> 25118076

Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial.

Claudia Torino1, Fabio Manfredini, Davide Bolignano, Filippo Aucella, Rossella Baggetta, Antonio Barillà, Yuri Battaglia, Silvio Bertoli, Graziella Bonanno, Pietro Castellino, Daniele Ciurlino, Adamasco Cupisti, Graziella D'Arrigo, Luciano De Paola, Fabrizio Fabrizi, Pasquale Fatuzzo, Giorgio Fuiano, Luigi Lombardi, Gaetano Lucisano, Piergiorgio Messa, Renato Rapanà, Francesco Rapisarda, Stefania Rastelli, Lisa Rocca-Rey, Chiara Summaria, Alessandro Zuccalà, Giovanni Tripepi, Luigi Catizone, Carmine Zoccali, Francesca Mallamaci.   

Abstract

BACKGROUND/AIMS: Scarce physical activity predicts shorter survival in dialysis patients. However, the relationship between physical (motor) fitness and clinical outcomes has never been tested in these patients.
METHODS: We tested the predictive power of an established metric of motor fitness, the Six-Minute Walking Test (6MWT), for death, cardiovascular events and hospitalization in 296 dialysis patients who took part in the trial EXCITE (ClinicalTrials.gov Identifier: NCT01255969).
RESULTS: During follow up 69 patients died, 90 had fatal and non-fatal cardiovascular events, 159 were hospitalized and 182 patients had the composite outcome. In multivariate Cox models - including the study allocation arm and classical and non-classical risk factors - an increase of 20 walked metres during the 6MWT was associated to a 6% reduction of the risk for the composite end-point (P=0.001) and a similar relationship existed between the 6MWT, mortality (P<0.001) and hospitalizations (P=0.03). A similar trend was observed for cardiovascular events but this relationship did not reach statistical significance (P=0.09).
CONCLUSIONS: Poor physical performance predicts a high risk of mortality, cardiovascular events and hospitalizations in dialysis patients. Future studies, including phase-2 EXCITE, will assess whether improving motor fitness may translate into better clinical outcomes in this high risk population.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25118076     DOI: 10.1159/000355798

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  28 in total

Review 1.  Physical exercise programs in CKD: lights, shades and perspectives [corrected].

Authors:  Filippo Aucella; Yuri Battaglia; Vincenzo Bellizzi; Davide Bolignano; Alessandro Capitanini; Adamasco Cupisti
Journal:  J Nephrol       Date:  2015-02-03       Impact factor: 3.902

Review 2.  Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD.

Authors:  Baback Roshanravan; Jorge Gamboa; Kenneth Wilund
Journal:  Am J Kidney Dis       Date:  2017-04-18       Impact factor: 8.860

3.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

Review 4.  Assessment of physical functioning in the clinical care of the patient with advanced kidney disease.

Authors:  Baback Roshanravan; Kushang V Patel
Journal:  Semin Dial       Date:  2019-05-01       Impact factor: 3.455

5.  Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial.

Authors:  Fabio Manfredini; Francesca Mallamaci; Graziella D'Arrigo; Rossella Baggetta; Davide Bolignano; Claudia Torino; Nicola Lamberti; Silvio Bertoli; Daniele Ciurlino; Lisa Rocca-Rey; Antonio Barillà; Yuri Battaglia; Renato Mario Rapanà; Alessandro Zuccalà; Graziella Bonanno; Pasquale Fatuzzo; Francesco Rapisarda; Stefania Rastelli; Fabrizio Fabrizi; Piergiorgio Messa; Luciano De Paola; Luigi Lombardi; Adamasco Cupisti; Giorgio Fuiano; Gaetano Lucisano; Chiara Summaria; Michele Felisatti; Enrico Pozzato; Anna Maria Malagoni; Pietro Castellino; Filippo Aucella; Samar Abd ElHafeez; Pasquale Fabio Provenzano; Giovanni Tripepi; Luigi Catizone; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2016-12-01       Impact factor: 10.121

6.  Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study.

Authors:  Nicola Lamberti; Pablo Jesùs López-Soto; Franco Guerzoni; Nicola Napoli; Vincenzo Gasbarro; Paolo Zamboni; Elpiniki Tsolaki; Maria Cristina Taddia; Maria Aurora Rodríguez-Borrego; Roberto Manfredini; Nino Basaglia; Fabio Manfredini
Journal:  Intern Emerg Med       Date:  2019-08-21       Impact factor: 3.397

Review 7.  Prehabilitation for the Frail Patient Approaching ESRD.

Authors:  Anoop Sheshadri; Kirsten L Johansen
Journal:  Semin Nephrol       Date:  2017-03       Impact factor: 5.299

Review 8.  Exercise training for adults undergoing maintenance dialysis.

Authors:  Amelie Bernier-Jean; Nadim A Beruni; Nicola P Bondonno; Gabrielle Williams; Armando Teixeira-Pinto; Jonathan C Craig; Germaine Wong
Journal:  Cochrane Database Syst Rev       Date:  2022-01-12

9.  Melatonin ingestion before intradialytic exercise improves immune responses in hemodialysis patients.

Authors:  Houssem Marzougui; Omar Hammouda; Imen Ben Dhia; Rami Maaloul; Ikram Agrebi; Hanen Chaker; Khaoula Kammoun; Mohamed Ben Hmida; Fatma Ayadi; Choumous Kallel; Tarak Driss; Mouna Turki; Hatem Masmoudi; Hend Hachicha
Journal:  Int Urol Nephrol       Date:  2020-09-23       Impact factor: 2.370

10.  Intradialytic training in patients with end-stage renal disease: a systematic review and meta-analysis of randomized clinical trials assessing the effects of five different training interventions.

Authors:  Filipe Ferrari; Lucas Helal; Thiago Dipp; Douglas Soares; Ângela Soldatelli; Andrew Lee Mills; Cláudio Paz; Mário César Carvalho Tenório; Marcelo Trotte Motta; Franklin Correa Barcellos; Ricardo Stein
Journal:  J Nephrol       Date:  2019-12-21       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.